Atricure Stock Current Valuation
| ATRC Stock | USD 40.96 0.37 0.90% |
Valuation analysis of AtriCure helps investors to measure AtriCure's intrinsic value by examining its available valuation indicators, including the cash flow records, the balance sheet account changes and income statement patterns. The current year's Enterprise Value Over EBITDA is expected to grow to -221.35. The current year's Enterprise Value Multiple is expected to grow to -221.35. Fundamental drivers impacting AtriCure's valuation include:
Overvalued
Today
Please note that AtriCure's price fluctuation is very steady at this time. Calculation of the real value of AtriCure is based on 3 months time horizon. Increasing AtriCure's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Since AtriCure is currently traded on the exchange, buyers and sellers on that exchange determine the market value of AtriCure Stock. However, AtriCure's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 40.96 | Real 32.03 | Target 45.11 | Hype 40.96 | Naive 36.98 |
The real value of AtriCure Stock, also known as its intrinsic value, is the underlying worth of AtriCure Company, which is reflected in its stock price. It is based on AtriCure's financial performance, growth prospects, management team, or industry conditions. The intrinsic value of AtriCure's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, or news.
Estimating the potential upside or downside of AtriCure helps investors to forecast how AtriCure stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of AtriCure more accurately as focusing exclusively on AtriCure's fundamentals will not take into account other important factors: AtriCure Company Current Valuation Analysis
AtriCure's Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.
Current AtriCure Current Valuation | 1.96 B |
Most of AtriCure's fundamental indicators, such as Current Valuation, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, AtriCure is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
AtriCure Current Valuation Driver Correlations
Understanding the fundamental principles of building solid financial models for AtriCure is extremely important. It helps to project a fair market value of AtriCure Stock properly, considering its historical fundamentals such as Current Valuation. Since AtriCure's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of AtriCure's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of AtriCure's interrelated accounts and indicators.
Click cells to compare fundamentals
AtriCure Current Valuation Historical Pattern
Today, most investors in AtriCure Stock are looking for potential investment opportunities by analyzing not only static indicators but also various AtriCure's growth ratios. Consistent increases or drops in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's current valuation growth rates may not be enough to decide which company is a better investment. That's why investors frequently use a static breakdown of AtriCure current valuation as a starting point in their analysis.
AtriCure Current Valuation |
| Timeline |
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.
| Competition |
In accordance with the recently published financial statements, AtriCure has a Current Valuation of 1.96 B. This is 86.34% lower than that of the Health Care Equipment & Supplies sector and 78.54% lower than that of the Health Care industry. The current valuation for all United States stocks is 88.2% higher than that of the company.
AtriCure Current Valuation Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses AtriCure's direct or indirect competition against its Current Valuation to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of AtriCure could also be used in its relative valuation, which is a method of valuing AtriCure by comparing valuation metrics of similar companies.AtriCure is currently under evaluation in current valuation category among its peers.
AtriCure ESG Sustainability
Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary and do not directly affect the long term financial condition, AtriCure's sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to AtriCure's managers, analysts, and investors.Environmental | Governance | Social |
AtriCure Fundamentals
| Return On Equity | -0.0839 | ||||
| Return On Asset | -0.0351 | ||||
| Profit Margin | (0.09) % | ||||
| Operating Margin | (0.06) % | ||||
| Current Valuation | 1.96 B | ||||
| Shares Outstanding | 48.75 M | ||||
| Shares Owned By Insiders | 3.18 % | ||||
| Shares Owned By Institutions | 96.82 % | ||||
| Number Of Shares Shorted | 1.47 M | ||||
| Price To Earning | 33.47 X | ||||
| Price To Book | 4.33 X | ||||
| Price To Sales | 4.46 X | ||||
| Revenue | 399.25 M | ||||
| Gross Profit | 334.72 M | ||||
| EBITDA | (8.11 M) | ||||
| Net Income | (30.44 M) | ||||
| Cash And Equivalents | 118.45 M | ||||
| Cash Per Share | 2.55 X | ||||
| Total Debt | 74.49 M | ||||
| Debt To Equity | 0.16 % | ||||
| Current Ratio | 3.66 X | ||||
| Book Value Per Share | 9.54 X | ||||
| Cash Flow From Operations | 4.48 M | ||||
| Short Ratio | 2.97 X | ||||
| Earnings Per Share | (0.83) X | ||||
| Price To Earnings To Growth | (1.18) X | ||||
| Target Price | 46.33 | ||||
| Number Of Employees | 1.2 K | ||||
| Beta | 1.41 | ||||
| Market Capitalization | 2 B | ||||
| Total Asset | 613.93 M | ||||
| Retained Earnings | (357.06 M) | ||||
| Working Capital | 191.68 M | ||||
| Current Asset | 74.75 M | ||||
| Current Liabilities | 31.59 M | ||||
| Net Asset | 613.93 M |
About AtriCure Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze AtriCure's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of AtriCure using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of AtriCure based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether AtriCure offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of AtriCure's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Atricure Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Atricure Stock:Check out AtriCure Piotroski F Score and AtriCure Altman Z Score analysis. For information on how to trade AtriCure Stock refer to our How to Trade AtriCure Stock guide.You can also try the Content Syndication module to quickly integrate customizable finance content to your own investment portal.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of AtriCure. If investors know AtriCure will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about AtriCure listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.83) | Revenue Per Share | Quarterly Revenue Growth 0.179 | Return On Assets | Return On Equity |
The market value of AtriCure is measured differently than its book value, which is the value of AtriCure that is recorded on the company's balance sheet. Investors also form their own opinion of AtriCure's value that differs from its market value or its book value, called intrinsic value, which is AtriCure's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because AtriCure's market value can be influenced by many factors that don't directly affect AtriCure's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between AtriCure's value and its price as these two are different measures arrived at by different means. Investors typically determine if AtriCure is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, AtriCure's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.